Back to Search Start Over

Dosimetric comparison of hippocampal-sparing technologies in patients with low-grade glioma.

Authors :
Williamson A
Houston P
Paterson J
Chalmers AJ
McLoone P
Fullerton N
Foo SY
James A
Nowicki S
Source :
Neuro-oncology advances [Neurooncol Adv] 2024 Aug 06; Vol. 6 (1), pp. vdae131. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).
Publication Year :
2024

Abstract

Background: Radiotherapy (RT) plays an integral role in the management of low-grade gliomas (LGG). Late toxicity from RT can cause progressive neurocognitive dysfunction. Radiation-induced damage to the hippocampus (HCP) plays a considerable role in memory decline. Advancements in photon planning software have resulted in the development of multi-criteria optimization (MCO) and HyperArc technologies which may improve HCP sparing while maintaining planning target volume (PTV) target coverage.<br />Methods: Three planning methods for hippocampal sparing (HS) were compared, volumetric modulated arc therapy (VMAT) without HS (VMAT_noHS), VMAT with HS (VMAT_HS), MCO with HS (MCO_HS), and HyperArc with HS (HyperArc_HS).<br />Results: Twenty-five patients were identified. The contralateral HCP was spared in 16 patients and bilateral HCP in 9 patients with superiorly located tumors. All 3 HS planning techniques showed significant reductions in dose to the spared HCP in contralateral cases but only VMAT_HS and MCO_HS achieved this in bilateral cases ( P  < .008). Only MCO_HS was superior to VMAT_HS in lowering the dose to both contralateral HCP and bilateral HCP in all measured metrics ( P  < .008). PTV and OAR (organ at risk) dose constraints were achieved for all plans.<br />Conclusions: This retrospective dosimetric study demonstrated the feasibility of HS for low-grade glioma. All 3 HS planning techniques achieved significant dose reductions to the spared contralateral hippocampus, but only MCO_HS and VMAT_HS achieved this in bilateral cases. MCO was superior to other planning techniques for sparing both bilateral and contralateral hippocampi.<br />Competing Interests: The authors have no relevant disclosures.<br /> (© The Author(s) 2024. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.)

Details

Language :
English
ISSN :
2632-2498
Volume :
6
Issue :
1
Database :
MEDLINE
Journal :
Neuro-oncology advances
Publication Type :
Academic Journal
Accession number :
39220244
Full Text :
https://doi.org/10.1093/noajnl/vdae131